bioRxivNeurosciencePreprint
Cell-type selective deletion of RSK2 reveals insights into altered signaling in Coffin-Lowry Syndrome
Hu Zhu, Ryan T. StrachaniD, Daniel J. UrbaniD, Martilias S. FarrelliD, Wesley K. Kroeze, Justin G. EnglishiD, Reid H. J. OlseniD, Bryan L. RothiD
- Citations
- 2
Abstract
Coffin-Lowry syndrome (CLS) is an X-linked syndromic form of mental retardation characterized by various skeletal dysmorphisms, moderate to severe mental retardation, and in some cases, psychosis. CLS is caused by loss-of-function mutations of the p90 ribosomal S6 kinase 2 (RPS6KA3) gene encoding a growth factor-regulated serine/threonine kinase, ribosomal S6 kinase 2 (RSK2). We previously identified RSK2 as a novel interacting protein that tonically inhibits 5-HT2A receptor signaling by phosphorylating Ser-314 within the third intracellular loop. To determine if RSK2 inhibits 5-HT2A receptor signaling in vivo and whether disruption of RSK2 could lead to schizophrenia-like behaviors - as is seen in some CLS patients - we genetically disrupted the function of RSK2 either globally or selectively in forebrain pyramidal neurons in mice. Both global and forebrain-selective RSK2 deletion augmented the locomotor responses to the psychotomimetic drugs phencyclidine (PCP) and amphetamine (AMPH). Significantly, forebrain-selective deletion of RSK2 augmented 5-HT2A receptor signaling as exemplified by enhanced 5-HT2A-mediated c-fos activation and head-twitch response without altering the levels or distribution of 5-HT2A receptor protein. Thus, RSK2 modulates 5HT2A receptor function in vivo, and disruption of RSK2 leads to augmented psychostimulant-induced responses reminiscent of those seen in many animal models of schizophrenia. These findings strengthen the association between 5-HT2A receptor dysfunction and psychosis, and provide a potential mechanism underlying the schizophrenia-like symptoms present in some CLS patients.\n\nHighlightsO_LIGlobal and cell-type-specific RSK2 knock-out mice were assessed behaviorally and pharmacologically\nC_LIO_LIAugmentation of amphetamine and PCP locomotor responses were seen in both global and forebrain-specific RSK2 KO mice\nC_LIO_LIAugmentation of 5-HT2A serotonin receptor function but not number was also observed\nC_LIO_LIThese alterations reveal insights into mechanisms potentially responsible for behavioral sequlae of Coffin-Lowry Syndrome\nC_LI
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Defective synaptic plasticity in a model of Coffin-Lowry Syndrome is rescued by simultaneously targeting PKA and MAPK pathways
Rong-Yu Liu, Yili Zhang, … John H. Byrne·bioRxiv·Jun 7, 2022
- Antipsychotic-like effects of the selective Rho-kinase 2 inhibitor KD025 in genetic and pharmacological mouse models of schizophrenia
Rinako Tanaka, Jingzhu Liao, … Kiyofumi Yamada·Molecular PsychiatryPeer-reviewed·Apr 1, 2026
- GABAergic deficits and schizophrenia-like behaviors in a mouse model carrying patient-derived neuroligin-2 R215H mutation
Dongyun Jiang, Zheng Wu, … Gong Chen·Molecular BrainPeer-reviewed·Jun 1, 2018
- Schizophrenia-associated 22q11.2 deletion elevates striatal acetylcholine and disrupts thalamostriatal projections to produce amotivation in mice
Mary H. Patton, Brett J.W. Teubner, … Stanislav S. Zakharenko·bioRxiv·Jun 20, 2025
- KCC2 Activation Reverses Neurophysiological and Behavioral Deficits in Female Rett Mice
Muhammad Nauman Arshad, Josephine Ng, … Stephen J. Moss·bioRxiv·Jan 14, 2026
- Schizophrenia-related cognitive dysfunction in the Cyclin-D2 knockout mouse model of ventral hippocampal hyperactivity
C. M. Grimm, S. Aksamaz, … D. Kaetzel·bioRxiv·May 14, 2018